Cycling at the interface between neurodevelopment and neurodegeneration

Cell Death and Differentiation

Volumn 9, Issue 12, 2002, Pages 1294-1306

  Nguyen, M D ^a,c   Mushynski, W E ^b   Julien, J P ^a  

^a RESEARCH INSTITUTE OF THE MCGILL UNIVERSITY HEALTH CENTRE   (Canada)

^b MCGILL UNIVERSITY   (Canada)

^c HARVARD MEDICAL SCHOOL   (United States)

Author keywords

Alzheimer; Amyotrophic lateral sclerosis; Cell cycle; Cyclin dependent kinases; Cytoskeleton; Neurodegeneration; Neurodevelopment

Indexed keywords

CELL CYCLE PROTEIN; CYCLIN DEPENDENT KINASE 2; CYCLIN DEPENDENT KINASE 4; CYCLIN DEPENDENT KINASE 5; CYCLIN DEPENDENT KINASE 6; PROTEIN P25; REGULATOR PROTEIN; TRANSCRIPTION FACTOR E2F;

ALZHEIMER DISEASE; AMYOTROPHIC LATERAL SCLEROSIS; APOPTOSIS; CELL CYCLE; CELL CYCLE G1 PHASE; CELL CYCLE S PHASE; CELL DEATH; CELL DIVISION; CELL PROLIFERATION; DEREGULATION; ENZYME REGULATION; GENE SILENCING; HUMAN; MITOSIS; NERVE CELL DIFFERENTIATION; NERVE DEGENERATION; NONHUMAN; PARKINSON DISEASE; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN INDUCTION; PROTEIN PHOSPHORYLATION; REVIEW; SENESCENCE;

ANIMALS; APOPTOSIS; CELL DIFFERENTIATION; CENTRAL NERVOUS SYSTEM; CYCLIN-DEPENDENT KINASES; GENES, CDC; HUMANS; NEURODEGENERATIVE DISEASES; NEURONS; SIGNAL TRANSDUCTION;

EID: 12244303616     PISSN: 13509047     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.cdd.4401108     Document Type: Review

References (105)

1. Dhavan R and Tsai LH (2001) A decade of CDK5. Nat. Rev. Mol. Cell Biol. 2: 749-759
2. Tannoch VJ, Hinds PW and Tsai LH (2000) Cell cycle control. Adv. Exp. Med. Biol. 465: 127-140
3. Morgan DO (1997) Cyclin-dependent kinases: engines, clocks, and microprocessors. Annu. Rev. Cell Dev. Biol. 13: 261-291
4. Okano HJ, Pfaff DW and Gibbs RB (1993) RB and Cdc2 expression in brain: correlations with 3H-thymidine incorporation and neurogenesis. J. Neurosci. 13: 2930-2938
5. Xiong W, Pestell R and Rosner MR (1997) Role of cyclins in neuronal differentiation of immortalized hippocampal cells. Mol. Cell Biol. 17: 6585-6597
6. Pavletich NP (1999) Mechanisms of cyclin-dependent kinase regulation: structures of Cdks, their cyclin activators, and Cip and INK4 inhibitors. J. Mol. Biol. 287: 821-828
7. Mueller PR, Coleman TR and Dunphy WG (1995) Cell cycle regulation of a Xenopus Wee1-like kinase. Mol. Biol. Cell 6: 119-134
8. Mueller PR, Coleman TR, Kumagai A and Dunphy WG (1995) Myt1: a membrane-associated inhibitory kinase that phosphorylates Cdc2 on both threonine-14 and tyrosine-15. Science 270: 86-90
9. Gu Y, Rosenblatt J and Morgan DO (1992) Cell cycle regulation of CDK2 activity by phosphorylation of Thr160 and Tyr15. EMBO J. 11: 3995-4005
10. Kumagai A and Dunphy WG (1995) Control of the Cdc2/cyclin B complex in Xenopus egg extracts arrested at a G2/M checkpoint with DNA synthesis inhibitors. Mol. Biol. Cell 6: 199-213
11. Dunphy WG and Kumagai A (1991) The cdc25 protein contains an intrinsic phosphatase activity. Cell 67: 189-196
12. Zukerberg LR, Patrick GN, Nikolic M, Humbert S, Wu CL, Lanier LM, Gertler FB, Vidal M, Van Etten RA and Tsai LH (2000) Cables links Cdk5 and c-Abl and facilitates Cdk5 tyrosine phosphorylation, kinase upregulation, and neurite outgrowth. Neuron 26: 633-646
13. Matsuura I and Wang JH (1996) Demonstration of cyclin-dependent kinase inhibitory serine/threonine kinase in bovine thymus. J. Biol. Chem. 271: 5443-5450
14. Sharma P, Sharma M, Amin ND, Albers RW and Pant HC (1999) Regulation of cyclin-dependent kinase 5 catalytic activity by phosphorylation. Proc. Natl. Acad. Sci. USA 96: 11156-11160
15. Tarricone C, Dhavan R, Peng J, Areces LB, Tsai LH and Musacchio A (2001) Structure and regulation of the CDK5-p25(nck5a)complex. Mol. Cell. 8: 657-669
16. Lee MH, Nikolic M, Baptista CA, Lai E, Tsai LH and Massague J (1996) The brain-specific activator p35 allows Cdk5 to escape inhibition by p27Kip1 in neurons. Proc. Natl. Acad. Sci. USA 93: 3259-3263
17. Ching YP, Pang AS, Lam WH, Oi RZ and Wang JH (2002) Identification of a neuronal Cdk5 activator-binding protein as Cdk5 inhibitor. J. Biol. Chem. 277: 15237-15240
18. Songyang Z, Lu KP, Kwon YT, Tsai LH, Filhol O, Cochet C, Brickey DA, Soderling TR, Bartleson C, Graves DJ, DeMaggio AJ, Hoekstra MF, Blenis J, Hunter T and Cantley LC (1996) A structural basis for substrate specificities of protein Ser/Thr kinases: primary sequence preference of casein kinases I and II, NIMA, phosphorylase kinase, calmodulin-dependent kinase II, CDK5, and Erk1. Mol. Cell. Biol. 16: 6486-6493
19. Julien JP and Mushynski WE (1998) Neurofilaments in health and disease. Prog. Nucleic. Acid. Res. Mol. Biol. 61: 1-23
20. Endicott JA and Noble ME (1998) Structural principles in cell-cycle control: beyond the CDKs. Structure 6: 535-541
21. Saha P, Eichbaum O, Silberman ED, Mayer BJ and Dutta A (1997) p21 CIP1 and Cdc25A: competition between an inhibitor and an activator of cyclin-dependent kinases. Mol. Cell. Biol. 17: 4338-4345
22. Wohlschlegel JA, Dwyer BT, Takeda DY and Dutta A (2001) Mutational analysis of the Cy motif from p21 reveals sequence degeneracy and specificity for different cyclin-dependent kinases. Mol. Cell. Biol. 21: 4868-4874
23. Tsai LH, Takahashi T, Caviness Jr VS and Harlow E (1993) Activity and expression pattern of cyclin-dependent kinase 5 in the embryonic mouse nervous system. Development 119: 1029-1040
24. Carey RG, Li B and DiCicco-Bloom E (2002) Pituitary adenylate cyclase activating polypeptide anti-mitogenic signaling in cerebral cortical progenitors is regulated by p57Kip2-dependent CDK2 activity.J. Neurosci. 22:1583-1591
25. Legrier ME, Ducray A, Propper A and Kastner A (2001) Region-specific expression of cell cycle inhibitors in the adult brain. Neuroreport 12: 3127-3131
26. Gill RM, Slack R, Kiess M and Hamel PA (1998) Regulation of expression and activity of distinct pRB, E2F, D-type cyclin, and CKI family members during terminal differentiation of P19 cells. Exp. Cell. Res. 244: 157-170
27. Berke JD, Sgambato V, Zhu PP, Lavoie B, Vincent M, Krause M and Hyman SE (2001) Dopamine and glutamate induce distinct stratal splice forms of Ania-6, an RNA polymerase II-associated cyclin. Neuron 32: 277-287
28. Lazzaro, MA, Albert PR and Julien JP (1997) A novel cdc2-related protein kinase expressed in the nervous system. J. Neurochem. 69: 348-364
29. Liu DX and Greene LA (2001) Neuronal apoptosis at the G1/S cell cycle checkpoint. Cell Tissue Res. 305: 217-228
30. Husseman JW, Nochlin D and Vincent I (2000) Mitotic activation: a convergent mechanism for a cohort of neurodegenerative diseases. Neurobiol. Aging 21: 815-828
31. Park DS, Obeidat A, Giovanni A and Greene LA (2000) Cell cycle regulators in neuronal death evoked by excitotoxic stress: implications for neurodegeneration and its treatment. Neurobiol. Aging 21: 771-781
32. Osuga H, Osuga S, Wang F, Fetni R, Hogan MJ, Slack RS, Hakim AM, Ikeda JE and Park DS (2000) Cyclin-dependent kinases as a therapeutic target for stroke. Proc. Natl. Acad. Sci. USA 97: 10254-10259
33. Ino H and Chiba T (2001) Cyclin-dependent kinase 4 and cyclin D1 are required for excitotoxin-induced neuronal cell death in vivo. J. Neurosci. 21: 6086-6094
34. Giovanni A, Keramaris E, Morris EJ, Hou ST, O'Hare M, Dyson N, Robertson GS, Slack RS and Park DS (2000) E2F1 mediates death of B-amyloid-treated cortical neurons in a manner independent of p53 and dependent on Bax and caspase 3. J. Biol. Chem. 275: 11553-11560
35. Liu DX and Greene LA (2001) Regulation of neuronal survival and death by E2F-dependent gene repression and derepression. Neuron 32: 425-438
36. Jordan-Sciutto KL, Malaiyandi LM and Bowser R (2002) Altered distribution of cell cycle transcriptional regulators during Alzheimer disease. J. Neuropathol. Exp. Neurol. 61: 358-367
37. Nguyen MD, Julien JP and Rivest S (2002) Innate immunity: the missing link in neuroprotection and neurodegeneration? Nat. Rev. Neurosci. 3: 216-227
38. Zhu X, Rottkamp CA, Raina AK, Brewer GJ, Ghanbari HA, Boux H and Smith MA (2000) Neuronal CDK7 in hippocampus is related to aging and Alzheimer disease. Neurobiol. Aging 21: 807-813
39. Vincent I, Bu B, Hudson K, Husseman J, Nochlin D and Jin L (2001) Constitutive Cdc25B tyrosine phosphatase activity in adult brain neurons with M phase-type alterations in Alzheimer's disease. Neuroscience 105: 639-650
40. Ding XL, Husseman J, Tomashevski A, Nochlin D, Jin LW and Vincent I (2000) The cell cycle Cdc25A tyrosine phosphatase is activated in degenerating postmitotic neurons in Alzheimer's disease. Am. J. Pathol. 157: 1983-1990
41. Vincent I, Jicha G, Rosado, M and Dickson DW (1997) Aberrant expression of mitotic cdc2/cyclin B1 kinase in degenerating neurons of Alzheimer's disease brain. J. Neurosci. 17: 3588-3598
42. Yang Y, Geldmacher DS and Herrup K (2001) DNA replication precedes neuronal cell death in Alzheimer's disease. J. Neurosci. 21: 2661-2668
43. Tsai LH, Delalle I, Caviness Jr VS, ChaeT and Harlow E (1994) p35 is a neural-specific regulatory subunit of cyclin-dependent kinase 5. Nature 371: 419-423
44. Ko J, Humbert S, Bronson RT, Takahashi S, Kulkarni AB, Li E and Tsai LH (2001) p35 and p39 are essential for cyclin-dependent kinase 5 function during neurodevelopment. J. Neurosci. 21: 6758-6771
45. Tang D, Yeung J, Lee KY, Matsushita M, Matsui H, Tomizawa K, Hatase O and Wang JH (1995) An isoform of the neuronal cyclin-dependent kinase 5 (Cdk5) activator. J. Biol. Chem. 270: 26897-26903
46. Patrick GN, Zukerberg L, Nikolic M, de la Monte S, Dikkes P and Tsai LH (1999) Conversion of p35 to p25 deregulates Cdk5 activity and promotes neurodegeneration. Nature 402: 615-622
47. Patzke H and Tsai LH (2002) Calpain-mediated cleavage of the cyclin-dependent kinase 5 activator p39 to p29. J. Biol. Chem.
48. Kwon YT and Tsai LH (1998) A novel disruption of cortical development in p35(-/-) mice distinct from reeler. J. Comp. Neurol. 395: 510-522
49. Chae T, Kwon YT, Bronson R, Dikkes P, Li E and Tsai LH (1997) Mice lacking p35, a neuronal specific activator of Cdk5, display cortical lamination defects, seizures, and adult lethality. Neuron 18: 29-42
50. Delalle I, Bhide PG, Caviness Jr VS and Tsai LH (1997) Temporal and spatial patterns of expression of p35, a regulatory subunit of cyclin-dependent kinase 5, in the nervous system of the mouse. J. Neurocytol. 26: 283-296
51. Ino H, Ishizuka. T, Chiba T and Tatibana M (1994) Expression of CDK5 (PSSALRE kinase), a neural cdc2-related protein kinase, in the mature and developing mouse central and peripheral nervous systems. Brain Res. 661: 196-206
52. Zheng M, Leung CL and Liem RK (1998) Region-specific expression of cyclin-dependent kinase 5 (cdk5) and its activators, p35 and p39, in the developing and adult rat central nervous system. J. Neurobiol. 35: 141-159
53. Cal XH, Tomizawa K, Tang D, Lu YF, Moriwaki A, Tokuda M, Nagahata S, Hatase O and Matsui H (1997) Changes in the expression of novel Cdk5 activator messenger RNA (p39nck5ai mRNA) during rat brain development. Neurosci. Res. 28: 355-360
54. Humbert S, Dhavan R and Tsai L (2000) p39 activates cdk5 in neurons, and is associated with the actin cytoskeleton. J. Cell. Sci. 113 (Pt 6): 975-983
55. Nikolic M, Chou MM, Lu W, Mayer BJ and Tsai LH (1998) The p35/Cdk5 kinase is a neuron-specific Rac effector that inhibits Pak1 activity. Nature 395: 194-198
56. Rashid T, Banerjee M and Nikolic M (2001) Phosphorylation of Pak1 by the p35/Cdk5 kinase affects neuronal morphology. J. Biol. Chem. 276: 49043-49052
57. Paglini G, Peris L, Diez-Guerra J, Quiroga S and Caceres A (2001) The Cdk5-p35 kinase associates with the Golgi apparatus and regulates membrane traffic. EMBO Rep. 2: 1139-1144
58. Ohshima T, Ward JM, Huh CG, Longenecker G, Veeranna, Pant HC, Brady RO, Martin LJ and Kulkarni AB (1996) Targeted disruption of the cyclin-dependent kinase 5 gene results in abnormal corticogenesis, neuronal pathology and perinatal death. Proc. Natl. Acad. Sci. USA 93: 11173-11178
59. Gilmore EC and Herrup K (2001) Neocortical cell migration: GABAergic neurons and cells in layers I and VI move in a cyclin-dependent kinase 5-independent manner. J. Neurosci. 21: 9690-9700
60. Tanaka T, Veeranna, Ohshima T, Rajan P, Amin ND, Cho A, Sreenath T, Pant HC, Brady RO and Kulkarni AB (2001) Neuronal cyclin-dependent kinase 5 activity is critical for survival. J. Neurosci. 21: 550-558
61. Ohshima T, Gilmore EC, Longenecker G, Jacobowitz DM, Brady RO, Herrup K and Kulkarni AB (1999) Migration defects of cdk5(-/-) neurons in the developing cerebellum is cell autonomous. J. Neurosci. 19: 6017-6026
62. Reiner O (2000) LIS1. let's interact sometimes (part 1). Neuron 28: 633-636
63. Smith DS, Niethammer M, Ayala R, Zhou Y, Gambello MJ, Wynshaw-Boris A and Tsai LH (2000) Regulation of cytoplasmic dynein behaviour and microtubule organization by mammalian Lis1. Nat. Cell Biol. 2: 767-775
64. Niethammer M, Smith DS, Ayala R, Peng J, Ko J, Lee MS, Morabito, M and Tsai LH (2000) NUDEL is a novel Cdk5 substrate that associates with LIS1 and cytoplasmic dynein. Neuron 28: 697-711
65. McEvilly RJ, de Diaz MO, Schonemann MD, Hooshmand F and Rosenfeld MG (2002) Transcriptional regulation of cortical neuron migration by POU domain factors. Science 295: 1528-1532
66. Rice DS and Curran T (2001) Role of the reelin signaling pathway in central nervous system development. Annu. Rev. Neurosci. 24: 1005-1039
67. Ohshima T, Ogawa M, Veeranna, Hirasawa M, Longenecker G, Ishiguro, K, Pant HC, Brady RO, Kulkarni AB and Mikoshiba K (2001) Synergistic contributions of cyclin-dependant kinase 5/p35 and Reelin/Dab1 to the positioning of cortical neurons in the developing mouse brain. Proc. Natl. Acad. Sci. USA 98: 2764-2769
68. Keshvara L, Magdaleno S, Benhayon D and Curran T (2002) Cyclin-dependent kinase 5 phosphorylates disabled 1 independently of Reelin signaling. J. Neurosci. 22: 4869-4877
69. Kwon YT, Gupta A, Zhou Y, Nikolic M and Tsai LH (2000) Regulation of N-cadherin-mediated adhesion by the p35-Cdk5 kinase. Curr. Biol. 10: 363-372
70. Kwon YT, Tsai LH and Crandall JE (1999) Callosal axon guidance defects in p35(-/-) mice. J. Comp. Neurol. 415: 218-229
71. Gupta A and Tsai LH (2001) Neuroscience. A kinase to dampen the effects of cocaine? Science 292: 236-237
72. Greengard P (2001) The neurobiology of slow synaptic transmission. Science 294: 1024-1030
73. Liu F, Ma XH, Ule J, Bibb JA, Nishi A, DeMaggio AJ, Yan Z, Naim AC and Greengard P (2001) Regulation of cyclin-dependent kinase 5 and casein kinase 1 by metabotropic glutamate receptors. Proc. Natl. Acad. Sci. USA 98: 11062-11068
74. Li BS, Zhang L, Takahashi S, Ma W, Jaffe H, Kulkarni AB and Pant HC (2002) Cyclin-dependent kinase 5 prevents neuronal apoptosis by negative regulation of c-Jun N-terminal kinase 3. EMBO J. 21: 324-333
75. Sharma P, Veeranna, Sharma M, Amin ND, Sihag RK, Grant P, Ahn N, Kulkarni AB and Pant HC (2002) Phosphorylation of MEK1 by cdk5/p35 down-regulates the mitogen-activated protein kinase pathway. J. Biol. Chem. 277: 528-534
76. Harada T, Morooka T, Ogawa S and Nishida E (2001) ERK induces p35, a neuron-specific activator of Cdk 5, through induction of Egr1. Nat. Cell. Biol. 3: 453-459
77. Ross S, Tienhaara A, Lee MS, Tsai LH and Gill G (2002) GC Box-binding Transcription Factors Control the Neuronal Specific Transcription of the Cyclin-dependent Kinase 5 Regulator p35. J. Biol. Chem. 277: 4455-4464
78. Fischer A, Sananbenesi F, SchrickC, Spiess J and Radulovic J (2002) Cyclin-dependent kinase 5 is required for associative learning. J. Neurosci. 22: 3700-3707
79. Tomizawa K, Ohta J, Matsushita M, Moriwaki A, Li ST, Takei K and Matsui H (2002) Cdk5/p35 regulates neurotransmitter release through phosphorylation and downregulation of P/Q-type voltage-dependent calcium channel activity. J. Neurosci. 22: 2590-2597
80. Matsuura I, Bondarenko VA, Maeda T, Kachi S, Yamazaki M, Usukura J, Hayashi F and Yamazaki A (2000) Phosphorylation by cyclin-dependent protein kinase 5 of the regulatory subunit of retinal cGMP phosphodiesterase. I. Identification of the kinase and its role in the turnoff of phosphodiesterase in vitro. J. Biol. Chem. 275: 32950-32957
81. Li BS, Sun MK, Zhang L, Takahashi S, Ma W, Vinade L, Kulkarni AB, Brady RO and Pant HC (2001) Regulation of NMDA receptors by cyclin-dependent kinase-5. Proc. Natl. Acad. Sci. USA 98: 12742-12747
82. Yamaguchi H, Ishiguro K, Uchida T, Takashima A, Lemere CA and Imahori K (1996) Preferential labeling of Alzheimer neurofibrillary tangles with antisera for tau protein kinase (TPK) I/glycogen synthase kinase-3 beta and cyclin-dependent kinase 5, a component of TPK II. Acta Neuropathol (Berl) 92: 232-241
83. Pei JJ, Grundke-Iqbal I, Iqbal K, Bogdanovic N, Winblad B and Cowburn RF (1998) Accumulation of cyclin-dependent kinase 5 (cdk5) in neurons with early stages of Alzheimer's disease neurofibrillary degeneration. Brain Res. 797: 267-277
84. Bajaj NP, Al-Sarraj ST, Anderson V, Kibble M, Leigh N and Miller CC (1998) Cyclin-dependent kinase-5 is associated with lipofuscin in motor neurones in amyotrophic lateral sclerosis, Neurosci. Lett. 245: 45-48
85. Nakamura S, Kawamoto Y, Nakano S, Akiguchi I and Kimura J (1997) p35nck5a and cyclin-dependent kinase 5 colocalize in Lewy bodies of brains with Parkinson's disease. Acta Neuropathol. (Berl) 94: 153-157
86. Green SL, Vulliet PR, Pinter MJ and Cork LC (1998) Alterations in cyclin-dependent protein kinase 5 (CDK5) protein levels, activity and immunocy-tochemistry in canine motor neuron disease. J. Neuropathol. Exp. Neurol. 57: 1070-1077
87. Nguyen MD, Lariviere RC and Julien JP (2001) Deregulation of Cdk5 in a mouse model of ALS: toxicity alleviated by perikaryal neurofilament inclusions. Neuron 30: 135-147
88. Patrick GN, Zhou P, Kwon YT, Howley PM and Tsai LH (1998) p35, the neuronal-specific activator of cyclin-dependent kinase 5 (Cdk5) is degraded by the ubiquitin-proteasome pathway. J. Biol. Chem. 273: 24057-24064
89. Lee MS, Kwon YT, Li M, Peng J, Friedlander RM and Tsai LH (2000) Neurotoxicity induces cleavage of p35 to p25 by calpain. Nature 405: 360-364
90. Sherman MY and Goldberg AL (2001) Cellular defenses against unfolded proteins: a cell biologist thinks about neurodegenerative diseases. Neuron 29: 15-32
91. Ahlijanian MK, Barrezueta NX, Williams RD, Jakowski A, Kowsz KP, McCarthy S, Coskran T, Carlo A, Seymour PA, Burkhardt JE, Nelson RB and McNeish JD (2000) Hyperphosphorylated tau and neurofilament and cytoskeletal disruptions in mice overexpressing human p25, an activator of cdk5. Proc. Natl. Acad. Sci. USA 97: 2910-2915
92. Bian F, Nath R, Solbocinski G, Booher RN, Lipinski WJ, Callahan MJ, Pack A, Wang KK and Walker LC (2002) Axonopathy, tau abnormalities, and dyskinesia, but no neurofibrillary tangles in p25-transgenic mice. J. Comp. Neurol. 446: 257-266
93. Van den Haute C, Spittaels K, Van Dorpe J, Lasrado R, Vandezande K, Laenen I, Geerts H and Van Leuven F (2001) Coexpression of human cdk5 and its activator p35 with human protein tau in neurons in brain of triple transgenic mice. Neurobiol. Dis. 8: 32-44
94. Alvarez A, Toro R, Caceres A and Maccioni RB (1999) Inhibition of tau phosphorylating protein kinase cdk5 prevents beta-amyloid-induced neuronal death. FEBS Lett. 459: 421-426
95. Wei W, Wang X and Kusiak JW (2002) Signaling events in Amyloid beta -peptide-induced neuronal death and IGF-I protection. J. Biol. Chem. 277: 17649-17656
96. Julien JP (2001) Amyotrophic lateral sclerosis, unfolding the toxicity of the misfolded. Cell 104: 581-591
97. Kriz J, Nguyen MD and Julien JP (2002) Minocycline Slows Disease Progression in a Mouse Model of Amyotrophic Lateral Sclerosis. Neurobiol. Dis. in press
98. Shah JV, Flanagan LA, Janmey PA and Leterrier JF (2000) Bidirectional translocation of neurofilaments along microtubules mediated in part by dynein/dynactin. Mol. Biol. Cell. 11: 3495-3508
99. Kreitzer G, Liao G and Gundersen GG (1999) Detyrosination of tubulin regulates the interaction of intermediate filaments with microtubules in vivo via a kinesin-dependent mechanism. Mol. Biol. Cell. 10: 1105-1118
100. Kesavapany S, Lau KF, McLoughlin DM, Brownlees J, Ackerley S, Leigh PN, Shaw CE and Miller CC (2001) p35/cdk5 binds and phosphorylates beta-catenin and regulates beta-catenin/presenilin-1 interaction. Eur. J. Neurosci. 13: 241-247
101. Zhang Z, Hartmann H, Do VM, Abramowski D, Sturchler-Pierrat C, Staufenbiel M, Sommer B, van de Wetering M, Clevers H, Saftig P, De Strooper B, He X and Yankner BA (1998) Destabilization of beta-catenin by mutations in presenilin-1 potentiates neuronal apoptosis. Nature 395: 698-702
102. Suske G (1999) The Sp-family of transcription factors. Gene 238: 291-300
103. Ino H and Chiba T (1996) Intracellular localization of cyclin-dependent kinase 5 (CDK5) in mouse neuron: CDK5 is located in both nucleus and cytoplasm. Brain Res. 732: 179-185
104. Philpott A, Porro EB, Kirschner MW and Tsai LH (1997) The role of cyclin-dependent kinase 5 and a novel regulatory subunit in regulating muscle differentiation and patterning. Genes Dev. 11: 1409-1421
105. 5a activity. J. Biol. Chem. 277: